Merck's cancer drug KEYTRUDA (pembrolizumab), combined with Padcev (enfortumab vedotin-ejfv), has received a positive recommendation from the European Medicines Agency's…
Read More

Merck's cancer drug KEYTRUDA (pembrolizumab), combined with Padcev (enfortumab vedotin-ejfv), has received a positive recommendation from the European Medicines Agency's…
Read More
Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has receivedten the green light in Europe—but it continues to be…
Read More